1. Osteoclastic microRNAs and their translational potential in skeletal diseases
- Author
-
Shinichi Nakano, Kazuki Inoue, and Baohong Zhao
- Subjects
0301 basic medicine ,Osteolysis ,Immunology ,Osteoporosis ,Osteoclasts ,Disease ,Bioinformatics ,Article ,Bone resorption ,Bone remodeling ,03 medical and health sciences ,0302 clinical medicine ,Osteogenesis ,Osteoclast ,microRNA ,medicine ,Humans ,Immunology and Allergy ,Genetic Predisposition to Disease ,business.industry ,medicine.disease ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,Gene Expression Regulation ,Protein Biosynthesis ,RNA Interference ,Bone Diseases ,business ,Homeostasis ,030215 immunology - Abstract
Skeleton undergoes constant remodeling process to maintain healthy bone mass. However, in pathological conditions, bone remodeling is deregulated, resulting in unbalanced bone resorption and formation. Abnormal osteoclast formation and activation play a key role in osteolysis, such as in rheumatoid arthritis and osteoporosis. As potential therapeutic targets or biomarkers, miRNAs have gained rapidly growing research and clinical attention. miRNA-based therapeutics is recently entering a new era for disease treatment. Such progress is emerging in treatment of skeletal diseases. In this review, we discuss miRNA biogenesis, advances in the strategies for miRNA target identification, important miRNAs involved in osteoclastogenesis and disease models, their regulated mechanisms, and translational potential and challenges in bone homeostasis and related diseases.
- Published
- 2019
- Full Text
- View/download PDF